These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3005834)

  • 1. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
    Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
    Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxation of vascular smooth muscle by HA-1004, an inhibitor of cyclic nucleotide-dependent protein kinase.
    Ishikawa T; Inagaki M; Watanabe M; Hidaka H
    J Pharmacol Exp Ther; 1985 Nov; 235(2):495-9. PubMed ID: 2997436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormones directly interact with vascular smooth muscle strips.
    Ishikawa T; Chijiwa T; Hagiwara M; Mamiya S; Hidaka H
    Mol Pharmacol; 1989 Jun; 35(6):760-5. PubMed ID: 2733694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of 4-chloro-3-ethyl phenol on internal Ca2+ stores in vascular smooth muscle and endothelial cells.
    Low AM; Sormaz L; Kwan CY; Daniel EE
    Br J Pharmacol; 1997 Oct; 122(3):504-10. PubMed ID: 9351507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ
    Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of diltiazem and nitroglycerin on cytosolic Ca2+ concentration and on force in the bovine ophthalmic artery.
    Hiroishi G; Kobayashi S; Nishimura J; Inomata H; Kanaide H
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2612-23. PubMed ID: 8977475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
    Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
    Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on calmodulin antagonistic effects of bepridil in intact and skinned fibres of smooth muscle.
    Reiermann HJ; Rüegg JC
    Arzneimittelforschung; 1986 Apr; 36(4):668-70. PubMed ID: 3487326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
    Silver PJ; Stull JT
    Mol Pharmacol; 1983 May; 23(3):665-70. PubMed ID: 6688120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of suloctidil on the contractions of isolated rat aortic strips induced by norepinephrine and CaCl2].
    Ishibashi A; Hanagata R; Horii D; Hisayama T; Takayanagi I
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):361-73. PubMed ID: 6323288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stellettamide-A, a novel inhibitor of calmodulin, isolated from a marine sponge.
    Abe Y; Saito S; Hori M; Ozaki H; Fusetani N; Karaki H
    Br J Pharmacol; 1997 Aug; 121(7):1309-14. PubMed ID: 9257908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of myosin light chain kinase phosphorylation in beta-adrenergic relaxation of tracheal smooth muscle.
    Miller JR; Silver PJ; Stull JT
    Mol Pharmacol; 1983 Sep; 24(2):235-42. PubMed ID: 6136904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
    Inagaki M; Kawamoto S; Itoh H; Saitoh M; Hagiwara M; Takahashi J; Hidaka H
    Mol Pharmacol; 1986 Jun; 29(6):577-81. PubMed ID: 2872589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modulation of coronary vessel tonus: molecular and cellular mechanisms].
    Busse R; Bassenge E
    Z Kardiol; 1984 Aug; 73(8):477-91. PubMed ID: 6093397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-induced quenching of intrinsic fluorescence in brain myosin V is linked to dissociation of calmodulin light chains.
    Cameron LC; Carvalho RN; Araujo JR; Santos AC; Tauhata SB; Larson RE; Sorenson MM
    Arch Biochem Biophys; 1998 Jul; 355(1):35-42. PubMed ID: 9647664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanisms underlying the midazolam-induced relaxation of the noradrenaline-contraction in rabbit mesenteric resistance artery.
    Shiraishi Y; Ohashi M; Kanmura Y; Yamaguchi S; Yoshimura N; Itoh T
    Br J Pharmacol; 1997 Jul; 121(6):1155-63. PubMed ID: 9249252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
    Zhang SP; Prozialeck WC; Weiss B
    Mol Pharmacol; 1990 Nov; 38(5):698-704. PubMed ID: 2146488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.